Stage iv colon cancer patients without dennd2d expression benefit more from neoadjuvant chemotherapy

HIGHLIGHTS

• who: Wen-juan Ma from the Patients and tissue samples One hundred eighty-one samples were obtained from patients at Sun YatSen University Cancer Center from May, to May, Informed consent was obtained from all the patients before tissue collection. All patients were diagnosed with initially resectable CRLM and received , or , surgical resection. All the patients were pathologically confirmed to have colon adenocarcinoma. And all the baseline information of patients was collected blindly, without knowing the expression level of DENND D. Studies involving human tissue samples were carried out in accordance with the guidelines approved by the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.